Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 193,965 | 744,844 | 582,073 | 406,895 | 204,289 |
| Depreciation Amortization | 26,511 | 104,596 | 76,901 | 50,434 | 25,057 |
| Income taxes - deferred | -5,028 | -3,377 | 4,049 | 4,193 | 5,244 |
| Accounts receivable | -37,531 | -33,141 | -49,050 | -50,721 | -54,735 |
| Accounts payable and accrued liabilities | -4,016 | 11,233 | 637 | 3,812 | 2,460 |
| Other Working Capital | -114,242 | -137,523 | -154,752 | -127,520 | -119,562 |
| Other Operating Activity | 55,047 | 68,914 | 85,724 | 71,284 | 61,669 |
| Operating Cash Flow | $114,706 | $755,546 | $545,582 | $358,377 | $124,422 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -31,838 | -119,549 | -87,761 | -42,744 | -20,163 |
| Net Acquisitions | N/A | -173,418 | -161,166 | -156,506 | N/A |
| Purchase Sale Intangibles | -10,000 | N/A | N/A | N/A | -4,424 |
| Other Investing Activity | -10,000 | 0 | 0 | 0 | -4,424 |
| Investing Cash Flow | $-41,838 | $-292,967 | $-248,927 | $-199,250 | $-24,587 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 326,500 | 73,500 | N/A | N/A | N/A |
| Debt Repayment | -75,000 | -50,000 | -50,000 | N/A | N/A |
| Common Stock Issued | 11,653 | 46,565 | N/A | N/A | 17,594 |
| Common Stock Repurchased | -276,633 | -762,339 | -517,522 | -335,739 | -147,245 |
| Other Financing Activity | 0 | -5,140 | 35,928 | 25,871 | 0 |
| Financing Cash Flow | $-13,480 | $-697,414 | $-531,594 | $-309,868 | $-129,651 |
| Exchange Rate Effect | 776 | -4,639 | -3,786 | -1,053 | -2,949 |
| Beginning Cash Position | 144,454 | 383,928 | 383,928 | 383,928 | 383,928 |
| End Cash Position | 204,618 | 144,454 | 145,203 | 232,134 | 351,163 |
| Net Cash Flow | $60,164 | $-239,474 | $-238,725 | $-151,794 | $-32,765 |
| Free Cash Flow | |||||
| Operating Cash Flow | 114,706 | 755,546 | 545,582 | 358,377 | 124,422 |
| Capital Expenditure | -31,838 | -119,549 | -87,761 | -42,744 | -20,163 |
| Free Cash Flow | 82,868 | 635,997 | 457,821 | 315,633 | 104,259 |